"Ecstasy" and serotonin neurotoxicity: New findings raise more questions

Archives of General Psychiatry

Volumn 58, Issue 10, 2001, Pages 907-908

  McCann, U D ^a   Ricaurte, G A ^a   Molliver, M E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; IODINE 123; SEROTONIN TRANSPORTER;

AMNESIA; BRAIN CORTEX; DRUG ABUSE; HUMAN; NEUROCHEMISTRY; NEUROTOXICITY; NOTE; SEROTONINERGIC NERVE CELL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0034787203     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.58.10.907     Document Type: Note

References (21)

1. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): Preliminary findings
2. Memory impairment in abstinent MDMA ("ecstasy") users
3. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
4. Cognitive performance in (±) 3,4-methylene-dioxymethamphetamine (MDMA, "ecstasy") users: A controlled study
5. Memory deficits associated with recreational use of "ecstasy" (MDMA)
6. Ecstasy (MDMA) effects upon mood and cognition: Before, during and after a Saturday night dance
7. Cognitive performance in recreational users of MDMA or "ecstasy": Evidence for memory deficits
8. Cognitive performance and serotonergic function in users of ecstasy
9. Memory impairment in abstinent MDMA ("ecstasy") users: A longitudinal investigation
10. Cognitive performance amongst recreational users of "ecstasy"
11. The relative contributions of ecstasy and cannabis to cognitive impairment
12. 123I beta-CIT: Pharmacological characterization of brain uptake in nonhuman primates
13. β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo
14. In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment
15. Serotonin transporters in ecstasy users
16. Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ("ecstasy") users
17. Altered serotonin innervation patterns in the forebrain of monkeys treated with (±)3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery
18. Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter
19. Neurotoxicity of MDMA and related compounds: Anatomic studies
20. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: Immunocytochemical evidence for neurotoxicity
21. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylene-dioxymethamphetamine (MDMA, "ecstasy")